meldepliktige handler fra primærinnsidere

← Alle transaksjoner

AQUA BIO TECHNOLOGY ASA - PRIMARY INSIDER NOTIFICATIONS

Aqua Bio Technology ASA (ABTEC) · publisert 2021-12-12 23:40 · vis på NewsWeb

Transaksjoner

PersonRolleTypeVolumPrisDatoISINHandelsplassTolket via
Ice Capital AS nærståendeClose associate of CEO Håvard Lindstrømsubscription71 42914 NOK2021-12-12–Outside a trading venuerules
RH Industri AS nærståendeClose associate of Board Member Roger Hofsethsubscription178 57114 NOK2021-12-12–Outside a trading venuerules
Espen Halvard Dahl nærståendeClose associate of Board Member Kristin Aasesubscription71 42914 NOK2021-12-12–Outside a trading venue 2 av 2 Notification and public disclosure of transactions by Primary Insiders and their Close Associates 5 Details of the person discharging managerial responsibilities/person closely associated b) Name Jan Petterson 6 Reason for the notification c) Position/status Board member d) Initial notification/ Amendment Initial notification 7 Details of the issuer c) Name Aqua Bio Technology d) LEI 529900RG33DF0N88RJ88 8 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted g) Description of the financial instrument, type of instrument Identification code ISIN: 0010307135 h) Nature of the transaction Subscription of shares in a private placement i) Price(s) and volume(s) Price(s) Volume(s) NOK 14 107,143 j) Aggregated information - Aggregated volume - Price 107,143 shares subscribed, each at a price of NOK 14. k) Date of the transaction 12 December 2021 l) Place of the transaction Outside a trading venuerules

Vedlegg

Meldingstekst

13.12.2021 00:40:04 CET | Aqua Bio Technology ASA | Mandatory notification of trade primary insiders Aqua Bio Technology ASA - Primary insider Notifications Reference is made to the stock exchange notice from Aqua Bio Technology ASA (the "Company") regarding the completion of a private placement to raise NOK 12.89 million. In the private placement Håvard Lindstrøm, CEO and primary insider the Company, has been allocated 71 429 shares at a price of NOK 14 per share, through his wholly owned company Ice Capital AS. Following such allocation, Håvard Lindstrøm and related parties will, upon issuance of shares in the private placement, hold 416 348 shares in the Company, corresponding to an ownership stake of 2.0% of the total outstanding shares in the Company. Roger Hofseth, board member and primary insider of ABT, has been allocated 178 571 shares today at a price of NOK 14 per share, through his wholly owned company RH Industri AS. Following such allocation, Roger Hofseth and related parties will, upon issuance of shares in the private placement, hold 4 693 475 shares in the Company, corresponding to an ownership stake of 22.76% of the total outstanding shares in the Company. Jan Petterson, board member and primary insider of ABT, has been allocated 107 143 shares today at a price of NOK 14 per share. Following such allocation, Jan Petterson and related parties will, upon issuance of shares in the private placement, hold 4 543 028 shares in the Company, corresponding to an ownership stake of 22.03% of the total outstanding shares in the Company. Espen Halvard Dahl, a close associate of Board member Kristin Aase who is a primary insider in the Company, has been allocated 71 429 shares at a price of NOK 14. Following such allocation, Espen Halvard Dahl, Kjeveortoped Espen Dahl AS and close associates (including Board member Kristin Aase) will, upon issuance of shares in the private placement, hold 1 477 707 shares in the company, corresponding to an ownership stake of 7.17% of the total outstanding shares in the Company. Further information is available in the attached forms. **** For further information, please contact Håvard Lindstrøm, CEO, telephone +47 941 32 288. This information is subject to the disclosure requirements in Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act § 5-12. Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skin care products has been, and will continue to be, an important part of the company's strategy going forward. Aqua Bio Technology is listed on Euronext Expand. DISCLOSURE REGULATION This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act. CONTACTS * Håvard Lindstrøm, 004794132288, hl@aquabiotech.no ABOUT AQUA BIO TECHNOLOGY ASA Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on Euronext Expand. ATTACHMENTS Download announcement as PDF.pdf - https://kommunikasjon.ntb.no/ir-files/17847556/1060/1427/Download%20announcement %20as%20PDF.pdf Ice Capital AS.pdf - https://kommunikasjon.ntb.no/ir-files/17847556/1060/1424/Ice%20Capital%20AS.pdf RH Industri AS.pdf - https://kommunikasjon.ntb.no/ir-files/17847556/1060/1425/RH%20Industri%20AS.pdf EH Dahl Jan Petterson.pdf - https://kommunikasjon.ntb.no/ir-files/17847556/1060/1426/EH%20Dahl%20%20Jan%20Pe tterson.pdf